Propionic Acid Market Size, Share & Trends Analysis Report By Application (Animal Feed, Calcium And Sodium Propionate, Cellulose Acetate Propionate), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Primary Immunodeficiency Disorders Market Growth & Trends
The global primary immunodeficiency disorders market size is expected to reach USD 11.14 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.4% from 2024 to 2030. The industry is experiencing significant growth, driven by multiple key factors. Rising incidences of genetic disorders, increased awareness among healthcare professionals, and advancements in diagnostic and therapeutic technologies are pivotal in expanding the industry.
A study published in The New England Journal of Medicine in December 2022 highlights the success of gene therapy for Artemis-deficient severe combined immunodeficiency (ART-SCID). By adding a healthy copy of the DCLRE1C gene to patients' stem cells, this therapy effectively restored T and B cell function. The study, involving 10 infants, showed significant immune recovery and reduced complications compared to traditional treatments. Researchers are optimistic about the therapy’s potential, though further long-term studies and broader trials are needed for FDA approval and to explore its applicability in diverse populations. The successful gene therapy for Artemis-deficient SCID boosts industry growth by demonstrating effective treatment for previously difficult-to-treat conditions. This advancement drives demand for gene therapy solutions and innovations in treatments. The positive outcomes from this study potentially leading to increased investment, broader adoption, and the development of new therapies, thereby expanding the industry for advanced treatments.
Moreover, several drug’s success highlights the potential for similar innovations, fostering industry expansion and encouraging further development of specialized therapies in the sector. For instance, in March 2023, Pharming Group leniolisib (Joenja) approved by the FDA as the first treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) in patients aged 12 and older. The approval follows a 12-week study demonstrating that leniolisib reduced lymph node size and improved na?ve B cell counts by 37% compared to placebo. The industry is expanding due to advancements in gene therapy and the approval of new treatments such as leniolisib. These innovations demonstrate effective solutions for previously difficult-to-treat conditions, driving increased investment and interest in the sector. The success ofthese therapies boosts market confidence and encourages further development of specialized treatments. As research progresses and new therapies emerge, the market for advanced immunodeficiency treatments is expected to continue its robust growth, ultimately benefiting patients and healthcare providers alike.
Primary Immunodeficiency Disorders Market Report Highlights
Primary Immunodeficiency Disorders Market Growth & Trends
The global primary immunodeficiency disorders market size is expected to reach USD 11.14 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.4% from 2024 to 2030. The industry is experiencing significant growth, driven by multiple key factors. Rising incidences of genetic disorders, increased awareness among healthcare professionals, and advancements in diagnostic and therapeutic technologies are pivotal in expanding the industry.
A study published in The New England Journal of Medicine in December 2022 highlights the success of gene therapy for Artemis-deficient severe combined immunodeficiency (ART-SCID). By adding a healthy copy of the DCLRE1C gene to patients' stem cells, this therapy effectively restored T and B cell function. The study, involving 10 infants, showed significant immune recovery and reduced complications compared to traditional treatments. Researchers are optimistic about the therapy’s potential, though further long-term studies and broader trials are needed for FDA approval and to explore its applicability in diverse populations. The successful gene therapy for Artemis-deficient SCID boosts industry growth by demonstrating effective treatment for previously difficult-to-treat conditions. This advancement drives demand for gene therapy solutions and innovations in treatments. The positive outcomes from this study potentially leading to increased investment, broader adoption, and the development of new therapies, thereby expanding the industry for advanced treatments.
Moreover, several drug’s success highlights the potential for similar innovations, fostering industry expansion and encouraging further development of specialized therapies in the sector. For instance, in March 2023, Pharming Group leniolisib (Joenja) approved by the FDA as the first treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) in patients aged 12 and older. The approval follows a 12-week study demonstrating that leniolisib reduced lymph node size and improved na?ve B cell counts by 37% compared to placebo. The industry is expanding due to advancements in gene therapy and the approval of new treatments such as leniolisib. These innovations demonstrate effective solutions for previously difficult-to-treat conditions, driving increased investment and interest in the sector. The success ofthese therapies boosts market confidence and encourages further development of specialized treatments. As research progresses and new therapies emerge, the market for advanced immunodeficiency treatments is expected to continue its robust growth, ultimately benefiting patients and healthcare providers alike.
Primary Immunodeficiency Disorders Market Report Highlights
- Based on region, North America accounted for largest market share of 45.39% in 2023. The market is driven by robust healthcare infrastructure, high prevalence, and proactive government initiatives in the region.
- Based on disease, antibody deficiency segment accounted for the largest share of 52.62% in disease segment in 2023. The growth can be attributed to its high prevalence, significant healthcare impact, and the development of targeted treatments. Increased awareness and advanced diagnostics also contribute to its substantial presence in the industry.
- Based on product, the immunoglobulin replacement therapy segment holds the largest share in the market accounted for 63.18% in 2023 owing to its essential role in managing antibody deficiencies. High demand for effective treatment, advancements in therapy, and the critical need for ongoing care contribute to its substantial market share.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PROPIONIC ACID MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million) (Kilotons)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Propionic Acid Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. PROPIONIC ACID MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Propionic Acid Market: Application Movement Analysis, 2023 & 2030 (USD Million) (Kilotons)
4.3. Animal Feed
4.3.1. Animal Feed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.4. Calcium and Sodium Propionate
4.4.1. Calcium and Sodium Propionate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.5. Cellulose Acetate Propionate
4.5.1. Cellulose Acetate Propionate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
CHAPTER 5. PROPIONIC ACID MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Propionic Acid Market Share, By Region, 2023 & 2030 (USD Million) (Kilotons)
5.2. North America
5.2.1. North America Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.2.2. U.S.
5.2.2.1. U. S. Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.2.3. Canada
5.2.3.1. Canada Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.2.4. Mexico
5.2.4.1. Mexico Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3. Europe
5.3.1. Europe Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3.2. UK
5.3.2.1. UK Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3.3. Germany
5.3.3.1. Germany Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3.4. France
5.3.4.1. France Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3.5. Italy
5.3.5.1. Italy Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.4. Asia Pacific
5.4.1. Asia Pacific Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.4.2. China
5.4.2.1. China Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.4.3. Japan
5.4.3.1. Japan Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.4.4. India
5.4.4.1. India Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.5. Latin America
5.5.1. Latin America Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.5.2. Brazil
5.5.2.1. Brazil Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.5.3. Argentina
5.5.3.1. Argentina Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.6.2. South Africa
5.6.2.1. South Africa Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. BASF SE
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. Dow
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Eastman Chemical Company
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. Perstorp
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. Otto Chemie Pvt. Ltd.
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. Merck KGaA
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. Celanese Corporation
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. OQ Chemicals GmbH
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives
6.4.9. Daicel Corporation
6.4.9.1. Participant’s Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Recent Developments/ Strategic Initiatives
6.4.10. SONTARA ORGANO
6.4.10.1. Participant’s Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Recent Developments/ Strategic Initiatives
6.4.11. KANTO KAGAKU.
6.4.11.1. Participant’s Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Recent Developments/ Strategic Initiatives
6.4.12. Junsei Chemical Co., Ltd.
6.4.12.1. Participant’s Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PROPIONIC ACID MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million) (Kilotons)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Propionic Acid Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. PROPIONIC ACID MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Propionic Acid Market: Application Movement Analysis, 2023 & 2030 (USD Million) (Kilotons)
4.3. Animal Feed
4.3.1. Animal Feed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.4. Calcium and Sodium Propionate
4.4.1. Calcium and Sodium Propionate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.5. Cellulose Acetate Propionate
4.5.1. Cellulose Acetate Propionate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
CHAPTER 5. PROPIONIC ACID MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
5.1. Propionic Acid Market Share, By Region, 2023 & 2030 (USD Million) (Kilotons)
5.2. North America
5.2.1. North America Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.2.2. U.S.
5.2.2.1. U. S. Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.2.3. Canada
5.2.3.1. Canada Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.2.4. Mexico
5.2.4.1. Mexico Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3. Europe
5.3.1. Europe Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3.2. UK
5.3.2.1. UK Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3.3. Germany
5.3.3.1. Germany Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3.4. France
5.3.4.1. France Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.3.5. Italy
5.3.5.1. Italy Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.4. Asia Pacific
5.4.1. Asia Pacific Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.4.2. China
5.4.2.1. China Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.4.3. Japan
5.4.3.1. Japan Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.4.4. India
5.4.4.1. India Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.5. Latin America
5.5.1. Latin America Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.5.2. Brazil
5.5.2.1. Brazil Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.5.3. Argentina
5.5.3.1. Argentina Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.6.2. South Africa
5.6.2.1. South Africa Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Propionic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. BASF SE
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/ Strategic Initiatives
6.4.2. Dow
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/ Strategic Initiatives
6.4.3. Eastman Chemical Company
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/ Strategic Initiatives
6.4.4. Perstorp
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/ Strategic Initiatives
6.4.5. Otto Chemie Pvt. Ltd.
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/ Strategic Initiatives
6.4.6. Merck KGaA
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/ Strategic Initiatives
6.4.7. Celanese Corporation
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/ Strategic Initiatives
6.4.8. OQ Chemicals GmbH
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/ Strategic Initiatives
6.4.9. Daicel Corporation
6.4.9.1. Participant’s Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Recent Developments/ Strategic Initiatives
6.4.10. SONTARA ORGANO
6.4.10.1. Participant’s Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Recent Developments/ Strategic Initiatives
6.4.11. KANTO KAGAKU.
6.4.11.1. Participant’s Overview
6.4.11.2. Financial Performance
6.4.11.3. Product Benchmarking
6.4.11.4. Recent Developments/ Strategic Initiatives
6.4.12. Junsei Chemical Co., Ltd.
6.4.12.1. Participant’s Overview
6.4.12.2. Financial Performance
6.4.12.3. Product Benchmarking
6.4.12.4. Recent Developments/ Strategic Initiatives
